Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effects of Mobilized Balance Platform Exercises on Balance Parameters in Patients With Knee Osteoarthritis

Effects of Mobilized Balance Platform Exercises on Balance Parameters, Functional Status, and Pain in Patients With Knee Osteoarthritis: A Randomized Controlled Trial

This prospective single-blind randomized controlled study aims to investigate the effects of mobilized balance platform exercises on balance parameters, pain, functional status, fear of falling, and kinesiophobia in patients with knee osteoarthritis. A total of 36 patients diagnosed with knee osteoarthritis will be recruited from the outpatient clinic of Gaziler Physical Medicine and Rehabilitation Training and Research Hospital.

Participants will be randomly assigned to one of two groups. The control group will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program consisting of knee strengthening, balance, range of motion, proprioceptive, and stretching exercises. The intervention group will receive the same conventional treatment in addition to mobilized balance platform exercises using the Huber 360 system.

Pain severity, functional status, balance parameters, fear of falling, and kinesiophobia will be evaluated before and after treatment by an assessor blinded to treatment allocation.

Studieoversikt

Studietype

Intervensjonell

Registrering (Antatt)

36

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

      • Ankara, Tyrkia (Türkiye)
        • Rekruttering
        • Gaziler physical therapy and rehabilitation
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Patients aged between 45 and 65 years
  • Diagnosis of knee osteoarthritis classified as Kellgren-Lawrence grade 2 or 3
  • Willingness to participate voluntarily in the study

Exclusion Criteria:

  • Presence of orthopedic knee implants
  • Kellgren-Lawrence grade 1 or grade 4 knee osteoarthritis
  • Sensory impairment
  • Diagnosis of malignancy
  • Unhealed fractures
  • Circulatory disorders
  • Infection around the knee joint
  • Severe hearing loss or visual impairment
  • Cognitive impairment
  • Uncontrolled hypertension or diabetes mellitus
  • Vestibular disorders causing balance problems, such as vertigo
  • Use of walking assistive devices such as canes or walkers

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Conventional Physical Therapy
Participants in this group will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program. The home exercise program will include knee strengthening, balance, range of motion, proprioceptive, and stretching exercises, performed 3 days per week for 20 minutes.
Participants will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program consisting of knee strengthening, balance, range of motion, proprioceptive, and stretching exercises performed 3 times per week for 20 minutes.
Eksperimentell: Mobilized Balance Platform Exercise
Participants in this group will receive conventional physical therapy including TENS in addition to mobilized balance platform exercises using the Huber 360 system. The exercise protocol will include quadriceps and core strengthening, proprioceptive, balance, and neuromuscular exercises, performed 3 days per week for 20 minutes.
Participants will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program consisting of knee strengthening, balance, range of motion, proprioceptive, and stretching exercises performed 3 times per week for 20 minutes.
Participants will perform mobilized balance platform exercises using the Huber 360 system. The exercise protocol will include quadriceps and core strengthening, proprioceptive training, balance exercises, and neuromuscular exercises specifically designed for patients with knee osteoarthritis. Sessions will be performed 3 times per week for 20 minutes.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Static and Dynamic Balance Parameters
Tidsramme: Before treatment and immediately after completion of the 8-week treatment program
Balance performance will be assessed using the Huber 360 balance assessment system. Measurements will include static balance with eyes open and eyes closed, single-leg balance performance, and limits of stability.
Before treatment and immediately after completion of the 8-week treatment program

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Pain Severity Assessed by Visual Analog Scale (VAS)
Tidsramme: Before treatment and immediately after completion of the 8-week treatment program
Pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS) for night pain, resting pain, and pain during movement. Higher scores indicate greater pain severity.
Before treatment and immediately after completion of the 8-week treatment program
Functional Status Assessed by WOMAC
Tidsramme: Before treatment and immediately after completion of the 8-week treatment program
Functional status will be evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Higher scores indicate worse pain, stiffness, and functional limitation.
Before treatment and immediately after completion of the 8-week treatment program
Functional Mobility Assessed by Timed Up and Go Test
Tidsramme: Before treatment and immediately after completion of the 8-week treatment program
Functional mobility and dynamic balance will be assessed using the Timed Up and Go Test. Shorter completion times indicate better functional mobility.
Before treatment and immediately after completion of the 8-week treatment program
Fear of Falling Assessed by the International Falls Efficacy Scale
Tidsramme: Before treatment and immediately after completion of the 8-week treatment program
Fear of falling during activities of daily living will be evaluated using the International Falls Efficacy Scale. Higher scores indicate greater concern about falling.
Before treatment and immediately after completion of the 8-week treatment program
Kinesiophobia Assessed by Tampa Scale for Kinesiophobia
Tidsramme: Before treatment and immediately after completion of the 8-week treatment program
Fear of movement and reinjury will be evaluated using the Tampa Scale for Kinesiophobia. Higher scores indicate greater fear of movement.
Before treatment and immediately after completion of the 8-week treatment program

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Sefa Gümrük Aslan, gaziler physcial therapy and rehabilitation hospital

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

4. mai 2026

Primær fullføring (Antatt)

30. september 2026

Studiet fullført (Antatt)

30. oktober 2026

Datoer for studieregistrering

Først innsendt

3. mai 2026

Først innsendt som oppfylte QC-kriteriene

3. mai 2026

Først lagt ut (Faktiske)

8. mai 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

8. mai 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

3. mai 2026

Sist bekreftet

1. mai 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • KOA-MBP-2026

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere